Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SIOX

Sio Gene Therapies (SIOX) Stock Price, News & Analysis

Sio Gene Therapies logo

About Sio Gene Therapies Stock (NASDAQ:SIOX)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.45
$0.48
50-Day Range
$0.38
$0.48
52-Week Range
$0.25
$0.50
Volume
40,400 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Remove Ads
Receive SIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter.

SIOX Stock News Headlines

DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
Sio Gene Therapies Inc SIOX
Sio Gene Therapies (NASDAQ: AXGT)
See More Headlines

SIOX Stock Analysis - Frequently Asked Questions

Sio Gene Therapies Inc. (NASDAQ:SIOX) posted its earnings results on Friday, November, 12th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.12.

Shares of Sio Gene Therapies reverse split on Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sio Gene Therapies investors own include Digital Turbine (APPS), CrowdStrike (CRWD), ChargePoint (CHPT), Vuzix (VUZI) and Okta (OKTA).

Company Calendar

Last Earnings
11/12/2021
Today
4/03/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SIOX
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
No Data
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:SIOX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners